I've hoped for a B injection for years, so very flexible. Either there are biologic reasons investors are not aware of (and Leo is), making that impractical or Leo chose to play small ball and not get it done. I'm betting on the latter, but have no way of knowing, either way.
Agree and exactly why the last BDD trial was specific for the colon... So knowing a pill therapeutic has more value than injection surprised we have not heard from Leo on this? He was always one to mention possibilities going forward and it's like he's given up...
Our response to the Merck news is that we believe B will be more effective and plan to pursue a pill delivery option once we confirm the data....
I believe we don’t know whether oral for Covid will work or not. We don’t know if there can be systemic absorption in the other areas where B has not been targeted as of yet. If there is systemic absorption and a therapeutic level is achieved it may reach targeted areas. It is systemic. Your geography is off for the Oralogic pill.